← Browse by Condition
Medical Condition

nk cell lymphoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT05995028 Phase 1
Recruiting

Universal 4SCAR7U Targeting CD7-positive Malignancies

Enrollment
30 pts
Location
China
Sponsor
Shenzhen Geno-Immune Medical I...
View Trial →